Glycation,receptor-mediated cell activation and vascular complications of diabetes

1. Thornalley PJ , Battah S , Ahmed N et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003;375:581–92.

2. Schiekofer S , Andrassy M , Chen J et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappa B in PBMCs. Diabetes 2003;52:621–33.

3. Thornalley PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Molec Biol 1998;44:1013–23.

4. Neeper M , Schmidt A-M , Brett J et al. Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins. J Biol Chem 1992;267:14998–5004.

5. Yonekura H , Yamamoto Y , Sakurai S et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochemical J 2003;370:1097–109.

6. Yamamoto Y , Kato I , Doi T et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001;108:261–8.

7. Wendt TM , Tanji N , Guo J et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003;162:1123–37.

8. Valencia JV , Weldon SC , Quinn D et al. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Ann Biochem 2004;324:68–78.

9. Valencia JV , Mone M , Zhang J , Weetall M , Buxton FP , Hughes TE. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 2004;53:743–51.

10. Hofmann MA , Drury S , Fu CF et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889–901.

11. Park JS , Svetkauskaite D , He QB et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370–7.

12. Treutiger CJ , Mullins GE , Johansson ASM et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375–85.

13. Medina L , Haltiwanger R. Calf thymus high mobility group proteins are nonenzymatically glycated but not significantly glycosylated. Glycobiology 1998;8:191–8.